Loading clinical trials...
Loading clinical trials...
Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daiy Valacyclovir in the Reduction of HSV-2 Recurrences and Viral Shedding
Conditions
Interventions
Valacyclovir
Placebo
Locations
1
United States
Community Care Building
Birmingham, Alabama, United States
Start Date
January 1, 2009
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
July 13, 2017
NCT01875588
NCT04929028
NCT07071623
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
University of Alabama at Birmingham
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions